You are here

A Study to Investigate the Effects on Blood Pressure and Pulse Rate of a Single 100mg Dose of Sildenafil in Patients With Benign Prostatic Hyperplasia Who Are Being Treated With Doxazosin

Last updated on February 22, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Laguna Woods, California, 92653 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Benign Prostatic Hyperplasia
Sex
Male
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
35-75 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- patients who weighed between 132 and 220 lb (60 and 100 kg) with benign prostatic
hyperplasia (BPH)

- a total PSA (prostate specific antigen) measurement of less than or equal to 10 µg/L
within the 12 months prior to screening, were currently on doxazosin treatment for
BPH, had been treated with doxazosin for a minimum of 2 months prior to first dose of
study medication, and had received a minimum of 4 mg doxazosin once daily (from
doxazosin supplied for this study) for 2 weeks prior to the first dose of study
medication.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- subjects with a recent history (i.e. within 6 months prior to screening) of stroke or
myocardial infarction

- subjects with severe cardiovascular disorders such as unstable angina or severe
congestive heart failure

- subjects with known hereditary degenerative retinal disorders, such as retinitis
pigmentosa

- subjects with a supine systolic/diastolic blood pressure of >170/100 mmHg or mmHg either at screening or at the pre-dose measurements

- subjects receiving any other antihypertensive therapy other than doxazosin in the 3
weeks prior to the first dose of study medication.

NCT00645034
Pfizer
Completed
A Study to Investigate the Effects on Blood Pressure and Pulse Rate of a Single 100mg Dose of Sildenafil in Patients With Benign Prostatic Hyperplasia Who Are Being Treated With Doxazosin

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now